Richard J. Battafarano

Richard J. Battafarano

Thoracic Surgery

300 Mason Lord Drive
Kimmel Cancer Center
Baltimore, MD 21224

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal epithelial cells.

The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal epithelial cells.

Journal: The Biochemical journal

Published: July 24, 2026

Expression of Concern: The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.

Expression of Concern: The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.

Journal: The Biochemical journal

Published: July 24, 2026

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.

Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.

Journal: Nature medicine

Published: July 18, 2025

Third Proceedings of The North American Airway Collaborative (NoAAC): Consensus Statement on Trial Design for Airway Stenosis.

Third Proceedings of The North American Airway Collaborative (NoAAC): Consensus Statement on Trial Design for Airway Stenosis.

Journal: JAMA otolaryngology-- head & neck surgery

Published: January 23, 2025

National Analysis of Anastomotic Leak and Subsequent Failure to Rescue After Esophagectomy.

National Analysis of Anastomotic Leak and Subsequent Failure to Rescue After Esophagectomy.

Journal: The Journal of surgical research

Published: October 06, 2024

Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy.

Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy.

Journal: Cancers

Published: September 17, 2024

Maryland's Global Budget Revenue Program and Equitable Access to Esophagectomy for Esophageal Cancer.

Maryland's Global Budget Revenue Program and Equitable Access to Esophagectomy for Esophageal Cancer.

Journal: The Journal of surgical research

Published: December 01, 2023

Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.

Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.

Journal: ESMO open

Published: June 13, 2023

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.

Journal: Nature medicine

Published: June 05, 2023

Discussion.

Discussion.

Journal: The Journal of thoracic and cardiovascular surgery

Published: August 29, 2022

Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation.

Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation.

Journal: Cancers

Published: July 29, 2022

The COVID-19 Era Is Associated With Delays in Esophageal Cancer Diagnosis and Treatment.

The COVID-19 Era Is Associated With Delays in Esophageal Cancer Diagnosis and Treatment.

Journal: The Journal of surgical research

Published: February 28, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026